There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
In the adult skeleton, bone formation is regulated by an event referred to as the
coupling of bone formation to resorption (i.e. formation is quantitatively linked
to resorption), which is thought to be mediated in part by osteogenic growth factor
molecules produced by bone cells. Of the various osteogenic growth factors identified
in bone, there is sufficient evidence to document an important role for the insulin-like
growth factor (IGF) system in mediating this coupling process. Studies on the basic
aspects of the IGF system reveal that it is complex and involves a number of components
which include the inhibitory IGF binding protein (IGFBP)-4 and stimulatory IGFBP-5
and their corresponding proteases. This complex regulatory scheme of the IGF component
system, together with the finding that all of the IGF system components are regulated
in bone cells by both local and systemic effectors of bone metabolism, underscores
the importance of the IGFs in mediating coupling of bone formation to resorption.
In addition, a number of in vitro and in vivo findings also suggest that the IGF system
could play a role in the positive (net gain of bone) or negative (net loss of bone)
uncoupling of bone formation to resorption.